Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS in de Novo Kidney Transplant Recipients
NCT00154245Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2004
- Primary completion
- Mar 2006
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate sodium in kidney transplantation, sponsored by Novartis. Primary endpoint: Graft function at 6 months. Started Jan 2004; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00154245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154245.